Company snapshot
- Ticker
- CDNA
- Exchange
- NGM
- Sector
- Healthcare
- Industry
- Diagnostics & Research
- Market cap
- $4.52B
- Employees
- 761
- Currency
- USD
- Website
- https://caredx.com
CareDx, Inc. provides solutions for improving outcomes for transplant patients and advancing organ health in the United States and internationally. The company provides AlloSure Kidney, a donor-derived cell-free DNA (dd-cfDNA) solution for kidney transplant patients; AlloMap Heart, a gene expression profiling solution for heart transplant patients; AlloSure Heart, a dd-cfDNA solution for heart transplant patients; and AlloSure Lung, a dd-cfDNA…
Latest coverage
- Why CareDx Stock Soared Today
October 30, 2026